Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Suspended 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 5Tumor-Agnostic 4Thoracic 4Genitourinary 3Gastrointestinal 3Other hematologic neoplasm 2Gynecologic 2Lymphoid 1Dermatologic 1CNS 1

Conditions

Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Patient Acceptance of Health Care 1Gastrointestinal Neoplasms 1Breast Neoplasms 1

Interventions

Oxaliplatin 297Fluorouracil 272Bevacizumab 235Gemcitabine 234Leucovorin 212Capecitabine 204pembrolizumab 200Nivolumab 157Irinotecan 156Cisplatin 148Specimen Handling 143Magnetic Resonance Spectroscopy 130130-nm albumin-bound paclitaxel 115Paclitaxel 109durvalumab 104Cetuximab 102Radiotherapy 96atezolizumab 92Biopsy 92Drug Therapy 91Albumin-Bound Paclitaxel 78tislelizumab 77Taxes 73Folfox protocol 68lenvatinib 67Carboplatin 65regorafenib 60Blood Specimen Collection 60trifluridine tipiracil drug combination 52Ipilimumab 52

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Focus Groups × Gastrointestinal × 1 year × Clear all
NCT06666192 2025-12-24

The Ohio State University (OSU) SCREEN Community Program

Ohio State University Comprehensive Cancer Center

Phase NA Recruiting
2,067 enrolled
BreastGastrointestinalGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colorectal Neoplasms

NCT04392050 2025-11-28

A Community-Based Educational Intervention to Improve Colorectal Cancer Screening

Thomas Jefferson University

Suspended
90 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06559462 2025-11-25

DPYD Nudges

Abramson Cancer Center at Penn Medicine

Phase NA Completed
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Patient Acceptance of Health Care

Data powered by HemOnc (CC BY 4.0) Colophon âš¡